IP Verse

Polymorphic And Pseudopolymorphic Forms Of Pharmaceutical Compound Nxl104 - EP3269717

The patent EP3269717 was granted to Pfizer Ireland Pharmaceuticals on Aug 9, 2023. The application was originally filed on Oct 8, 2010 under application number EP17182561A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3269717

PFIZER IRELAND PHARMACEUTICALS
Application Number
EP17182561A
Filing Date
Oct 8, 2010
Status
Patent Maintained As Amended
May 12, 2023
Grant Date
Aug 9, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBNov 26, 2019LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONFR2921060
DESCRIPTIONUS6417175
DESCRIPTIONUS6906055
DESCRIPTIONUS7419973
DESCRIPTIONWO0210172
DESCRIPTIONWO03063864
OPPOSITIONEP2135959
OPPOSITIONUS7112592
SEARCHWO0210172

Non-Patent Literature (NPL) Citations (10) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- AI NGUYEN, L. et al., "Chiral drugs: an overview", Int. J. Biomed. Sci., (20060000), vol. 2, no. 2, pages 85 - 100, XP055377728-
OPPOSITION- H. G. BRITTAIN, "Methods for the characterization of polymorphs", Polymorphism in pharmaceutical solids, New York, (19990000), vol. 95, pages 235 - 238, XP008098996-
OPPOSITION- "international nonproprietary names for pharmaceutical substances (INN)", WHO Drug Information, (20100000), vol. 24, no. 2, pages 125 - 128, XP055660406-
OPPOSITION- J. P . GRIFFIN et al., "The textbook of pharmaceutical medicine", BMJ Books, London, (20060000), pages 96 - 127-
OPPOSITION- TARRAL, A. et al., 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) meeting, San Francisco, (20090912), XP055659411-
OPPOSITION- BYRN, S., "Pharmaceutical Solids: A strategic Approach to Regulatory Considerations", Pharmaceutical Research, (19950700), vol. 12, no. 7, pages 945 - 954, XP000996386
OPPOSITION- LIVERMORE, D.M. et al., "NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum .beta.-lactamases and carbapenemases", J. Antimicrob. Chemother., (20080000), vol. 62, no. 5, pages 1053 - 1056, XP002582640
OPPOSITION- FUKUDA, Y., "New APPROACHES TO OVERCOMING BACTERIAL Resistance", Drugs Future, (20090000), vol. 34, no. 2, pages 127 - 136, XP055659416
SEARCH- BONNEFOY ALAIN ET AL, "In vitro activity of AVE1330A, an innovative broad-spectrum non-.beta.-lactam .beta.-lactamase inhibitor", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, (2004), vol. 54, no. 2, pages 410 - 417, XP002582639 [A] 1-12 * the whole document *
SEARCH- LIVERMORE DAVID M. ET AL, "NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum .beta.-lactamases and carbapenemases", JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, (2008), vol. 62, no. 5, pages 1053 - 1056, XP002582640 [A] 1-12 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents